1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Stem Cell Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Cell Culturing 1.2.3 Cell Separation 1.2.4 Cell Analysis 1.2.5 Molecular Analysis 1.2.6 Others 1.3 Market by Application 1.3.1 Global Cancer Stem Cell Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Stem Cell Based Cancer Therapy 1.3.3 Targeted CSCs 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Cancer Stem Cell Market Perspective (2018-2029) 2.2 Cancer Stem Cell Growth Trends by Region 2.2.1 Global Cancer Stem Cell Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Cancer Stem Cell Historic Market Size by Region (2018-2023) 2.2.3 Cancer Stem Cell Forecasted Market Size by Region (2024-2029) 2.3 Cancer Stem Cell Market Dynamics 2.3.1 Cancer Stem Cell Industry Trends 2.3.2 Cancer Stem Cell Market Drivers 2.3.3 Cancer Stem Cell Market Challenges 2.3.4 Cancer Stem Cell Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Stem Cell Players by Revenue 3.1.1 Global Top Cancer Stem Cell Players by Revenue (2018-2023) 3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2018-2023) 3.2 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cancer Stem Cell Revenue 3.4 Global Cancer Stem Cell Market Concentration Ratio 3.4.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2022 3.5 Cancer Stem Cell Key Players Head office and Area Served 3.6 Key Players Cancer Stem Cell Product Solution and Service 3.7 Date of Enter into Cancer Stem Cell Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Stem Cell Breakdown Data by Type 4.1 Global Cancer Stem Cell Historic Market Size by Type (2018-2023) 4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2024-2029) 5 Cancer Stem Cell Breakdown Data by Application 5.1 Global Cancer Stem Cell Historic Market Size by Application (2018-2023) 5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Cancer Stem Cell Market Size (2018-2029) 6.2 North America Cancer Stem Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Cancer Stem Cell Market Size by Country (2018-2023) 6.4 North America Cancer Stem Cell Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Cancer Stem Cell Market Size (2018-2029) 7.2 Europe Cancer Stem Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Cancer Stem Cell Market Size by Country (2018-2023) 7.4 Europe Cancer Stem Cell Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cancer Stem Cell Market Size (2018-2029) 8.2 Asia-Pacific Cancer Stem Cell Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Cancer Stem Cell Market Size by Region (2018-2023) 8.4 Asia-Pacific Cancer Stem Cell Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Cancer Stem Cell Market Size (2018-2029) 9.2 Latin America Cancer Stem Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Cancer Stem Cell Market Size by Country (2018-2023) 9.4 Latin America Cancer Stem Cell Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cancer Stem Cell Market Size (2018-2029) 10.2 Middle East & Africa Cancer Stem Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Cancer Stem Cell Market Size by Country (2018-2023) 10.4 Middle East & Africa Cancer Stem Cell Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific, Inc. 11.1.1 Thermo Fisher Scientific, Inc. Company Detail 11.1.2 Thermo Fisher Scientific, Inc. Business Overview 11.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction 11.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.1.5 Thermo Fisher Scientific, Inc. Recent Development 11.2 AbbVie, Inc. 11.2.1 AbbVie, Inc. Company Detail 11.2.2 AbbVie, Inc. Business Overview 11.2.3 AbbVie, Inc. Cancer Stem Cell Introduction 11.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.2.5 AbbVie, Inc. Recent Development 11.3 Merck KGaA 11.3.1 Merck KGaA Company Detail 11.3.2 Merck KGaA Business Overview 11.3.3 Merck KGaA Cancer Stem Cell Introduction 11.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2018-2023) 11.3.5 Merck KGaA Recent Development 11.4 Bionomics 11.4.1 Bionomics Company Detail 11.4.2 Bionomics Business Overview 11.4.3 Bionomics Cancer Stem Cell Introduction 11.4.4 Bionomics Revenue in Cancer Stem Cell Business (2018-2023) 11.4.5 Bionomics Recent Development 11.5 Lonza 11.5.1 Lonza Company Detail 11.5.2 Lonza Business Overview 11.5.3 Lonza Cancer Stem Cell Introduction 11.5.4 Lonza Revenue in Cancer Stem Cell Business (2018-2023) 11.5.5 Lonza Recent Development 11.6 Stemline Therapeutics, Inc. 11.6.1 Stemline Therapeutics, Inc. Company Detail 11.6.2 Stemline Therapeutics, Inc. Business Overview 11.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction 11.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.6.5 Stemline Therapeutics, Inc. Recent Development 11.7 Miltenyi Biotec 11.7.1 Miltenyi Biotec Company Detail 11.7.2 Miltenyi Biotec Business Overview 11.7.3 Miltenyi Biotec Cancer Stem Cell Introduction 11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2018-2023) 11.7.5 Miltenyi Biotec Recent Development 11.8 PromoCell GmbH 11.8.1 PromoCell GmbH Company Detail 11.8.2 PromoCell GmbH Business Overview 11.8.3 PromoCell GmbH Cancer Stem Cell Introduction 11.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2018-2023) 11.8.5 PromoCell GmbH Recent Development 11.9 MacroGenics, Inc. 11.9.1 MacroGenics, Inc. Company Detail 11.9.2 MacroGenics, Inc. Business Overview 11.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction 11.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.9.5 MacroGenics, Inc. Recent Development 11.10 OncoMed Pharmaceuticals, Inc. 11.10.1 OncoMed Pharmaceuticals, Inc. Company Detail 11.10.2 OncoMed Pharmaceuticals, Inc. Business Overview 11.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction 11.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.10.5 OncoMed Pharmaceuticals, Inc. Recent Development 11.11 Irvine Scientific 11.11.1 Irvine Scientific Company Detail 11.11.2 Irvine Scientific Business Overview 11.11.3 Irvine Scientific Cancer Stem Cell Introduction 11.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2018-2023) 11.11.5 Irvine Scientific Recent Development 11.12 STEMCELL Technologies Inc. 11.12.1 STEMCELL Technologies Inc. Company Detail 11.12.2 STEMCELL Technologies Inc. Business Overview 11.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction 11.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.12.5 STEMCELL Technologies Inc. Recent Development 11.13 Sino Biological Inc. 11.13.1 Sino Biological Inc. Company Detail 11.13.2 Sino Biological Inc. Business Overview 11.13.3 Sino Biological Inc. Cancer Stem Cell Introduction 11.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.13.5 Sino Biological Inc. Recent Development 11.14 BIOTIME, Inc. 11.14.1 BIOTIME, Inc. Company Detail 11.14.2 BIOTIME, Inc. Business Overview 11.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction 11.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2018-2023) 11.14.5 BIOTIME, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cancer Stem Cell Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Cell Culturing Table 3. Key Players of Cell Separation Table 4. Key Players of Cell Analysis Table 5. Key Players of Molecular Analysis Table 6. Key Players of Others Table 7. Global Cancer Stem Cell Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Cancer Stem Cell Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 9. Global Cancer Stem Cell Market Size by Region (2018-2023) & (US$ Million) Table 10. Global Cancer Stem Cell Market Share by Region (2018-2023) Table 11. Global Cancer Stem Cell Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 12. Global Cancer Stem Cell Market Share by Region (2024-2029) Table 13. Cancer Stem Cell Market Trends Table 14. Cancer Stem Cell Market Drivers Table 15. Cancer Stem Cell Market Challenges Table 16. Cancer Stem Cell Market Restraints Table 17. Global Cancer Stem Cell Revenue by Players (2018-2023) & (US$ Million) Table 18. Global Cancer Stem Cell Market Share by Players (2018-2023) Table 19. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cell as of 2022) Table 20. Ranking of Global Top Cancer Stem Cell Companies by Revenue (US$ Million) in 2022 Table 21. Global 5 Largest Players Market Share by Cancer Stem Cell Revenue (CR5 and HHI) & (2018-2023) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Cancer Stem Cell Product Solution and Service Table 24. Date of Enter into Cancer Stem Cell Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Cancer Stem Cell Market Size by Type (2018-2023) & (US$ Million) Table 27. Global Cancer Stem Cell Revenue Market Share by Type (2018-2023) Table 28. Global Cancer Stem Cell Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 29. Global Cancer Stem Cell Revenue Market Share by Type (2024-2029) Table 30. Global Cancer Stem Cell Market Size by Application (2018-2023) & (US$ Million) Table 31. Global Cancer Stem Cell Revenue Market Share by Application (2018-2023) Table 32. Global Cancer Stem Cell Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 33. Global Cancer Stem Cell Revenue Market Share by Application (2024-2029) Table 34. North America Cancer Stem Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. North America Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million) Table 36. North America Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million) Table 37. Europe Cancer Stem Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 38. Europe Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million) Table 39. Europe Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million) Table 40. Asia-Pacific Cancer Stem Cell Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 41. Asia-Pacific Cancer Stem Cell Market Size by Region (2018-2023) & (US$ Million) Table 42. Asia-Pacific Cancer Stem Cell Market Size by Region (2024-2029) & (US$ Million) Table 43. Latin America Cancer Stem Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Latin America Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million) Table 45. Latin America Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million) Table 46. Middle East & Africa Cancer Stem Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 47. Middle East & Africa Cancer Stem Cell Market Size by Country (2018-2023) & (US$ Million) Table 48. Middle East & Africa Cancer Stem Cell Market Size by Country (2024-2029) & (US$ Million) Table 49. Thermo Fisher Scientific, Inc. Company Detail Table 50. Thermo Fisher Scientific, Inc. Business Overview Table 51. Thermo Fisher Scientific, Inc. Cancer Stem Cell Product Table 52. Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 53. Thermo Fisher Scientific, Inc. Recent Development Table 54. AbbVie, Inc. Company Detail Table 55. AbbVie, Inc. Business Overview Table 56. AbbVie, Inc. Cancer Stem Cell Product Table 57. AbbVie, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 58. AbbVie, Inc. Recent Development Table 59. Merck KGaA Company Detail Table 60. Merck KGaA Business Overview Table 61. Merck KGaA Cancer Stem Cell Product Table 62. Merck KGaA Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 63. Merck KGaA Recent Development Table 64. Bionomics Company Detail Table 65. Bionomics Business Overview Table 66. Bionomics Cancer Stem Cell Product Table 67. Bionomics Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 68. Bionomics Recent Development Table 69. Lonza Company Detail Table 70. Lonza Business Overview Table 71. Lonza Cancer Stem Cell Product Table 72. Lonza Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 73. Lonza Recent Development Table 74. Stemline Therapeutics, Inc. Company Detail Table 75. Stemline Therapeutics, Inc. Business Overview Table 76. Stemline Therapeutics, Inc. Cancer Stem Cell Product Table 77. Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 78. Stemline Therapeutics, Inc. Recent Development Table 79. Miltenyi Biotec Company Detail Table 80. Miltenyi Biotec Business Overview Table 81. Miltenyi Biotec Cancer Stem Cell Product Table 82. Miltenyi Biotec Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 83. Miltenyi Biotec Recent Development Table 84. PromoCell GmbH Company Detail Table 85. PromoCell GmbH Business Overview Table 86. PromoCell GmbH Cancer Stem Cell Product Table 87. PromoCell GmbH Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 88. PromoCell GmbH Recent Development Table 89. MacroGenics, Inc. Company Detail Table 90. MacroGenics, Inc. Business Overview Table 91. MacroGenics, Inc. Cancer Stem Cell Product Table 92. MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 93. MacroGenics, Inc. Recent Development Table 94. OncoMed Pharmaceuticals, Inc. Company Detail Table 95. OncoMed Pharmaceuticals, Inc. Business Overview Table 96. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Product Table 97. OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 98. OncoMed Pharmaceuticals, Inc. Recent Development Table 99. Irvine Scientific Company Detail Table 100. Irvine Scientific Business Overview Table 101. Irvine Scientific Cancer Stem Cell Product Table 102. Irvine Scientific Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 103. Irvine Scientific Recent Development Table 104. STEMCELL Technologies Inc. Company Detail Table 105. STEMCELL Technologies Inc. Business Overview Table 106. STEMCELL Technologies Inc. Cancer Stem Cell Product Table 107. STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 108. STEMCELL Technologies Inc. Recent Development Table 109. Sino Biological Inc. Company Detail Table 110. Sino Biological Inc. Business Overview Table 111. Sino Biological Inc. Cancer Stem Cell Product Table 112. Sino Biological Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 113. Sino Biological Inc. Recent Development Table 114. BIOTIME, Inc. Company Detail Table 115. BIOTIME, Inc. Business Overview Table 116. BIOTIME, Inc. Cancer Stem Cell Product Table 117. BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2018-2023) & (US$ Million) Table 118. BIOTIME, Inc. Recent Development Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Stem Cell Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Cancer Stem Cell Market Share by Type: 2022 VS 2029 Figure 3. Cell Culturing Features Figure 4. Cell Separation Features Figure 5. Cell Analysis Features Figure 6. Molecular Analysis Features Figure 7. Others Features Figure 8. Global Cancer Stem Cell Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 9. Global Cancer Stem Cell Market Share by Application: 2022 VS 2029 Figure 10. Stem Cell Based Cancer Therapy Case Studies Figure 11. Targeted CSCs Case Studies Figure 12. Cancer Stem Cell Report Years Considered Figure 13. Global Cancer Stem Cell Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Cancer Stem Cell Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Cancer Stem Cell Market Share by Region: 2022 VS 2029 Figure 16. Global Cancer Stem Cell Market Share by Players in 2022 Figure 17. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Stem Cell as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Cancer Stem Cell Revenue in 2022 Figure 19. North America Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Cancer Stem Cell Market Share by Country (2018-2029) Figure 21. United States Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Cancer Stem Cell Market Share by Country (2018-2029) Figure 25. Germany Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Cancer Stem Cell Market Share by Region (2018-2029) Figure 33. China Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Cancer Stem Cell Market Share by Country (2018-2029) Figure 41. Mexico Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Cancer Stem Cell Market Share by Country (2018-2029) Figure 45. Turkey Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Cancer Stem Cell Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 48. AbbVie, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 49. Merck KGaA Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 50. Bionomics Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 51. Lonza Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 52. Stemline Therapeutics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 53. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 54. PromoCell GmbH Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 55. MacroGenics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 56. OncoMed Pharmaceuticals, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 57. Irvine Scientific Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 58. STEMCELL Technologies Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 59. Sino Biological Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 60. BIOTIME, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2018-2023) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Thermo Fisher Scientific, Inc. AbbVie, Inc. Merck KGaA Bionomics Lonza Stemline Therapeutics, Inc. Miltenyi Biotec PromoCell GmbH MacroGenics, Inc. OncoMed Pharmaceuticals, Inc. Irvine Scientific STEMCELL Technologies Inc. Sino Biological Inc. BIOTIME, Inc.